Cargando…
Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study
BACKGROUND: For genetic conditions associated with neurodevelopmental disorder (GCAND), developmental domains such as motor ability, thinking and learning, social abilities, and communication are potential intervention targets. Performance on measures of developmental concepts can be expressed using...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843928/ https://www.ncbi.nlm.nih.gov/pubmed/36650450 http://dx.doi.org/10.1186/s11689-022-09474-6 |
_version_ | 1784870507035754496 |
---|---|
author | Farmer, Cristan Thurm, Audrey Troy, Jesse D. Kaat, Aaron J. |
author_facet | Farmer, Cristan Thurm, Audrey Troy, Jesse D. Kaat, Aaron J. |
author_sort | Farmer, Cristan |
collection | PubMed |
description | BACKGROUND: For genetic conditions associated with neurodevelopmental disorder (GCAND), developmental domains such as motor ability, thinking and learning, social abilities, and communication are potential intervention targets. Performance on measures of developmental concepts can be expressed using several types of scores. Norm-referenced scores are intended for the diagnostic context, allowing for the identification of impairment relative to age-based expectations, and can exhibit dramatic floor effects when used in individuals with more significant limitations. Person ability scores, which are derived via Rasch analysis or item response theory, are available on many standardized tests and are intended to measure within-person change. However, they have not been used or evaluated as primary endpoints in GCAND clinical trials. In this study, we simulated a series of parallel-arm clinical trials under several chronological age and impairment conditions, to compare empirically the power and type I error rate of operationalizing test performance using ability scores rather than norm-referenced scores. RESULTS: Using the Vineland Adaptive Behavior Scales as the example, we demonstrated an advantage in statistical power of ability scores over norm-referenced scores at extreme levels of impairment. This advantage was at least partially driven by floor effects in norm-referenced scores. For simulated conditions where impairment was less severe, ability scores outperformed norm-referenced scores, but they were more similar. The type I error rate closely approximated the nominal type I error rate of 5% for both scores. CONCLUSION: The results of this simulation demonstrate a substantial power and interpretative advantage of ability scores over norm-referenced scores for studies of GCAND that will enroll participants with high levels of impairment. These results are expected to generalize to studies of developmental concepts, regardless of the etiology or specific test. However, the relative advantage of ability scores is expected to be even greater for tests with a higher floor than the Vineland. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11689-022-09474-6. |
format | Online Article Text |
id | pubmed-9843928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98439282023-01-18 Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study Farmer, Cristan Thurm, Audrey Troy, Jesse D. Kaat, Aaron J. J Neurodev Disord New Method BACKGROUND: For genetic conditions associated with neurodevelopmental disorder (GCAND), developmental domains such as motor ability, thinking and learning, social abilities, and communication are potential intervention targets. Performance on measures of developmental concepts can be expressed using several types of scores. Norm-referenced scores are intended for the diagnostic context, allowing for the identification of impairment relative to age-based expectations, and can exhibit dramatic floor effects when used in individuals with more significant limitations. Person ability scores, which are derived via Rasch analysis or item response theory, are available on many standardized tests and are intended to measure within-person change. However, they have not been used or evaluated as primary endpoints in GCAND clinical trials. In this study, we simulated a series of parallel-arm clinical trials under several chronological age and impairment conditions, to compare empirically the power and type I error rate of operationalizing test performance using ability scores rather than norm-referenced scores. RESULTS: Using the Vineland Adaptive Behavior Scales as the example, we demonstrated an advantage in statistical power of ability scores over norm-referenced scores at extreme levels of impairment. This advantage was at least partially driven by floor effects in norm-referenced scores. For simulated conditions where impairment was less severe, ability scores outperformed norm-referenced scores, but they were more similar. The type I error rate closely approximated the nominal type I error rate of 5% for both scores. CONCLUSION: The results of this simulation demonstrate a substantial power and interpretative advantage of ability scores over norm-referenced scores for studies of GCAND that will enroll participants with high levels of impairment. These results are expected to generalize to studies of developmental concepts, regardless of the etiology or specific test. However, the relative advantage of ability scores is expected to be even greater for tests with a higher floor than the Vineland. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11689-022-09474-6. BioMed Central 2023-01-17 /pmc/articles/PMC9843928/ /pubmed/36650450 http://dx.doi.org/10.1186/s11689-022-09474-6 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | New Method Farmer, Cristan Thurm, Audrey Troy, Jesse D. Kaat, Aaron J. Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study |
title | Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study |
title_full | Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study |
title_fullStr | Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study |
title_full_unstemmed | Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study |
title_short | Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study |
title_sort | comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study |
topic | New Method |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843928/ https://www.ncbi.nlm.nih.gov/pubmed/36650450 http://dx.doi.org/10.1186/s11689-022-09474-6 |
work_keys_str_mv | AT farmercristan comparingabilityandnormreferencedscoresasclinicaltrialoutcomesforneurodevelopmentaldisabilitiesasimulationstudy AT thurmaudrey comparingabilityandnormreferencedscoresasclinicaltrialoutcomesforneurodevelopmentaldisabilitiesasimulationstudy AT troyjessed comparingabilityandnormreferencedscoresasclinicaltrialoutcomesforneurodevelopmentaldisabilitiesasimulationstudy AT kaataaronj comparingabilityandnormreferencedscoresasclinicaltrialoutcomesforneurodevelopmentaldisabilitiesasimulationstudy |